» Articles » PMID: 22888246

Enhanced Absorption of Hydroxysafflor Yellow A Using a Self-double-emulsifying Drug Delivery System: in Vitro and in Vivo Studies

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2012 Aug 14
PMID 22888246
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Hydroxysafflor yellow A (HSYA), the main active ingredient of the safflower plant (Carthamus tinctorius L.), is a hydrophilic drug with low oral bioavailability. Water-in-oil-in-water (w/o/w) double emulsions may enhance the oral absorption of HSYA. In this study, we prepared a self-double-emulsifying drug delivery system (SDEDDS) to improve the absorption of HSYA. SDEDDS consists of water in oil emulsions and hydrophilic surfactants that can self-emulsify into w/o/w double emulsions in the aqueous gastrointestinal environment. Confocal laser scanning micrographs showed that spherical droplets were uniformly distributed in the dispersion medium with narrow particle size distribution and could form fine w/o/w double emulsions upon dilution in dispersion medium with gentle stirring. The dispersed oil droplets contained small dispersed aqueous droplets consistent with the characteristics of double emulsions. Furthermore, in vitro cellular experiments were performed to study the mechanism of the absorption promoting effect of SDEDDS. The accumulation of rhodamine-123 in Caco-2 cells was used to evaluate the efflux transport of p-glycoprotein inhibitor. Histopathologic studies on the rat intestine showed that SDEDDS can cause mucosal damage to a certain degree of toxicity, however this was not serious. These results suggest that SDEDDS can greatly improve the oral absorption of HSYA. Given the toxicity demonstrated to the small intestine, the formulation prescription should be improved to enhance security in the future.

Citing Articles

Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect.

Wang Y, An J, Zhou J, Chang L, Zhang Q, Peng F Front Pharmacol. 2025; 15:1495393.

PMID: 39877386 PMC: 11772350. DOI: 10.3389/fphar.2024.1495393.


Quercetin improves the protection of hydroxysafflor yellow a against cerebral ischemic injury by modulating of blood-brain barrier and src-p-gp-mmp-9 signalling.

Li X, Yang Y, Feng P, Wang H, Zheng M, Zhu Y Heliyon. 2024; 10(10):e31002.

PMID: 38803916 PMC: 11128878. DOI: 10.1016/j.heliyon.2024.e31002.


Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability.

Ifrah S, Dahan A, Debotton N Pharmaceutics. 2023; 15(10).

PMID: 37896277 PMC: 10610354. DOI: 10.3390/pharmaceutics15102518.


Nanoemulsions of Hydroxysafflor Yellow A for Enhancing Physicochemical and In Vivo Performance.

Zhang Y, Zhong C, Wang Q, Zhang J, Zhao H, Huang Y Int J Mol Sci. 2023; 24(10).

PMID: 37240000 PMC: 10218444. DOI: 10.3390/ijms24108658.


Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation .

Ma P, Huang J, Liu J, Zhu Y, Chen J, Chen J J Cancer. 2023; 14(5):759-769.

PMID: 37056390 PMC: 10088884. DOI: 10.7150/jca.82410.


References
1.
Lutz R, Aserin A, Wicker L, Garti N . Release of electrolytes from W/O/W double emulsions stabilized by a soluble complex of modified pectin and whey protein isolate. Colloids Surf B Biointerfaces. 2009; 74(1):178-85. DOI: 10.1016/j.colsurfb.2009.07.014. View

2.
Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G . Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm. 2004; 278(1):119-31. DOI: 10.1016/j.ijpharm.2004.03.001. View

3.
Liu Y, Zhou Z, Chen P . Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Clin Exp Pharmacol Physiol. 2007; 35(2):211-6. DOI: 10.1111/j.1440-1681.2007.04814.x. View

4.
Qi X, Wang L, Zhu J, Hu Z, Zhang J . Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability. Int J Pharm. 2011; 409(1-2):245-51. DOI: 10.1016/j.ijpharm.2011.02.047. View

5.
Wang S, Sun M, Ping Q . Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats. Int J Pharm. 2008; 358(1-2):198-204. DOI: 10.1016/j.ijpharm.2008.03.006. View